Switch to:
Haemonetics Corp (NYSE:HAE)
EV/EBITDA
15.56 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Haemonetics Corp's enterprise value is $2,024.3 Mil. Haemonetics Corp's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2013 was $128.0 Mil. Therefore, Haemonetics Corp's EV/EBITDA ratio for today is 15.56.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Haemonetics Corp's stock price is $33.82. Haemonetics Corp's earnings per share for the trailing twelve months (TTM) ended in Dec. 2013 was $0.72. Therefore, Haemonetics Corp's P/E Ratio for today is 46.90.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Haemonetics Corp's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=2024.262/128.027
=15.81

Haemonetics Corp's current Enterprise Value is $2,024.3 Mil.
Haemonetics Corp's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2013 was 36.448 (Mar. 2013 ) + 9.583 (Jun. 2013 ) + 43.329 (Sep. 2013 ) + 38.667 (Dec. 2013 ) = $128.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Haemonetics Corp's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=33.82/0.72
=46.97

Haemonetics Corp's share price for today is $33.82.
Haemonetics Corp's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2013 was 0.24 (Mar. 2013 ) + -0.15 (Jun. 2013 ) + 0.32 (Sep. 2013 ) + 0.31 (Dec. 2013 ) = $0.72.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Haemonetics Corp Annual Data

Mar04Mar05Mar06Mar07Mar08Mar09Mar10Mar11Mar12Mar13
ev2ebitda 9.2710.608.6010.2913.1210.4610.649.3711.0919.91

Haemonetics Corp Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebitda 8.679.2311.0913.0919.1820.1319.9122.7519.1519.06
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide